Frequently Asked Questions
The market is segmented based on The size in 2023 is USD 6.56 billion. The market share is projected to grow at a CAGR of 6.70% and reach USD 11.03 billion by 2031.
.
The Global Insulin Glargine Market size was valued at USD 6.56 USD Billion in 2023.
The Global Insulin Glargine Market is projected to grow at a CAGR of 6.7% during the forecast period of 2024 to 2031.
The major players operating in the market include Biocon, Sanofi, Aventis, Novo Nordisk, Lilly, LGM Pharma, Trumac Healthcare, Gan & Lee Pharmaceuticals, ADOCIA, Lupin Ltd, WOCKHARDT, Cipla , Pfizer , Biogenomics Limited, Loka Biosciences, Amigoz Lifesciences, Endocrine Technologies , Alfa Chemical Corp, Accurate Chemical & Scientific Corporation, Spectrum Chemical Mfg Corp, Sekisui Diagnostics LLC.
